CN116063536B - 抗人MxA单克隆抗体及其制备方法和应用 - Google Patents
抗人MxA单克隆抗体及其制备方法和应用 Download PDFInfo
- Publication number
- CN116063536B CN116063536B CN202211306838.4A CN202211306838A CN116063536B CN 116063536 B CN116063536 B CN 116063536B CN 202211306838 A CN202211306838 A CN 202211306838A CN 116063536 B CN116063536 B CN 116063536B
- Authority
- CN
- China
- Prior art keywords
- mxa
- antibody
- antigen
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211306838.4A CN116063536B (zh) | 2022-10-24 | 2022-10-24 | 抗人MxA单克隆抗体及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211306838.4A CN116063536B (zh) | 2022-10-24 | 2022-10-24 | 抗人MxA单克隆抗体及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116063536A CN116063536A (zh) | 2023-05-05 |
CN116063536B true CN116063536B (zh) | 2023-07-25 |
Family
ID=86177668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211306838.4A Active CN116063536B (zh) | 2022-10-24 | 2022-10-24 | 抗人MxA单克隆抗体及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116063536B (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6180102B1 (en) * | 1994-08-08 | 2001-01-30 | Kyowa Hakko Kogyo Co., Ltd. | Monoclonal antibody to human Mx protein MxA |
US6200559B1 (en) * | 1996-10-31 | 2001-03-13 | Von Wussow Peter | Use of antibodies against MxA or MxB to determine levels of type I interferons in vivo |
CN101570742A (zh) * | 2009-04-13 | 2009-11-04 | 苏州大学 | 人抗粘病毒蛋白A-hMxA的单克隆抗体及其制备和应用 |
CN109725152A (zh) * | 2018-12-13 | 2019-05-07 | 厦门万泰凯瑞生物技术有限公司 | 一种抗病毒蛋白MxA微粒子化学发光免疫分析检测试剂盒 |
CN110724670B (zh) * | 2019-10-31 | 2021-04-13 | 浙江蓝盾药业有限公司 | 杂交瘤细胞株3h4、抗体及其应用 |
CN114805586A (zh) * | 2022-04-14 | 2022-07-29 | 天津华科泰生物技术有限公司 | 抗MxA单克隆抗体组合物及其应用 |
CN114755409A (zh) * | 2022-04-27 | 2022-07-15 | 南京艾拓生命科技有限公司 | 一种定量检测MxA蛋白的免疫荧光层析试剂盒及其制备方法 |
-
2022
- 2022-10-24 CN CN202211306838.4A patent/CN116063536B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN116063536A (zh) | 2023-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109937212B (zh) | B7-h3抗体、其抗原结合片段及其医药用途 | |
CN112250763B (zh) | 靶向SARS-CoV-2冠状病毒的抗体及其诊断和检测用途 | |
CN111518203B (zh) | 用于新型冠状病毒检测的试剂盒 | |
CN112851804B (zh) | 一种人源抗新型冠状病毒(SARS-CoV-2)的中和活性单克隆抗体 | |
JP2005528914A5 (zh) | ||
CN109336973B (zh) | 抗转铁蛋白抗体及其用途 | |
CN106866820A (zh) | 一种用于捕获肿瘤细胞的抗人角蛋白18的单克隆抗体及其应用 | |
CN108727488B (zh) | 抗诺如病毒gii.17单克隆抗体的制备和应用 | |
TW201904998A (zh) | 不對稱異二聚fc-scfv融合抗globo h及抗cd3雙特異性抗體及其於癌症治療上之用途 | |
CN112480250A (zh) | 一种抗人骨桥蛋白的抗体及其应用 | |
CN113227148A (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
CN116063536B (zh) | 抗人MxA单克隆抗体及其制备方法和应用 | |
CN106008708B (zh) | 一种人乙型肝炎病毒x蛋白的单克隆抗体及用途 | |
CN113683692B (zh) | SARS-CoV-2 N蛋白抗体及其应用 | |
CN113603786B (zh) | 特异性结合SARS-CoV-2 S蛋白和N蛋白的双特异性抗体 | |
CN113880948B (zh) | 抗ca724抗体或其抗原结合片段及其制备方法和应用 | |
JP5821198B2 (ja) | 抗il28b抗体及びこれを用いたil28bの測定方法 | |
CN111763255B (zh) | 一种经基因修饰的vegfa蛋白及其单克隆抗体与应用 | |
KR20230042301A (ko) | 샘플에서 sars-cov-2 단백질을 검출하기 위한 개선된 방법 및 키트 | |
WO2021188851A1 (en) | Antibodies against mucin 17 and uses thereof | |
CN117043192B (zh) | 针对IL-13Rα2的抗体及其应用 | |
RU2737466C1 (ru) | Гуманизированное нейтрализующее антитело к интерферону-бета человека | |
CN112979798B (zh) | 一种包含c反应蛋白抗原结合结构域的分离的结合蛋白 | |
WO2021238854A1 (zh) | 抗SARS-CoV-2刺突蛋白的单克隆抗体及其制备方法和用途 | |
WO2024008094A1 (zh) | 抗cd20抗体的单克隆抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 2013, Building A, Fubao Xiuyu Business Building, No. 77 Fuxing West Road, Baoding City, Hebei Province, 071052 Applicant after: Baoding Guolan Biotechnology Co.,Ltd. Address before: Room 2013, Building A, Fubao Xiuyu Business Building, No. 77 Fuxing West Road, Baoding City, Hebei Province, 071052 Applicant before: Hebei Keyi Biotechnology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Anti human MxA monoclonal antibody and its preparation method and application Effective date of registration: 20230828 Granted publication date: 20230725 Pledgee: Hebei Baoding Rural Commercial Bank Co.,Ltd. Pledgor: Baoding Guolan Biotechnology Co.,Ltd. Registration number: Y2023980054308 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |